$RIGL

$50.74 +$0.19 (0.38%) Close

$RIGL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 18.7M shares outstanding

Who owns RIGL?

By type of holder

Institutions 88.7% Insiders 3.3% Everyone else 8.0%

Concentration Top 10 holders own 55.0%

BlackRock, Inc. 10.4% · Soleus Capital Management, L.P. 9.9%

Institutional ownership

88.7%

+2.0 pts vs last qtr

Institutional holders

158

+4 vs last qtr

Net shares bought

+379.2K

by institutions in Q2 2026

New / sold out

34 / 30

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Soleus Capital Management, L.P. +1.8M
Armistice Capital, LLC +392.0K

Biggest sellers in Q2 2026

Qube Research & Technologies Ltd SOLD OUT −343.9K
Marshall Wace, LLP −231.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$306K

3 notices from 2 people

Shares covered

9.0K

0.05% of the company

Arranged in advance

52%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Ali-Jackson Kamil Director 10b5-1 $160K
Moos Walter H Director $145K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2012–FY2025

+151.3%

+10.78% a year

Each share's claim on the business

−60.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $102M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years81% Under 1 year19%

Quarterly turnover

24.4%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting RIGL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	1.9M	10.40%	+170.9K (+9.6%)	2024	0.0%
Shares held by quarter Peak holding1.9M (Q2'26) Change over 8 quarters+381.9K Share of the company10.400% BlackRock, Inc.'s full portfolio →
SC Soleus Capital Management, L.P.	1.8M	9.87%	+1.8M (+18335.0%)	2024	2.5%
Shares held by quarter Peak holding1.8M (Q2'26) Change over 8 quarters+908.7K Share of the company9.870% Soleus Capital Management, L.P.'s full portfolio →

BlackRock, Inc.

1.9M

% of company

10.40%

Change vs last qtr

+170.9K (+9.6%)

Held since

2024

Soleus Capital Management, L.P.

1.8M

% of company

9.87%

Change vs last qtr

+1.8M (+18335.0%)

Held since

2024

28 more super investors behind a free account

See every manager holding Rigel Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting RIGL on Form N-PORT; together they hold 34.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$25.4M	650.3K	3.48%	0.24%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$21.7M	555.8K	2.98%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$25.4M

% of company

3.48%

% of the fund

0.24%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$21.7M

% of company

2.98%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Rigel Pharmaceuticals, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RR Rodriguez Raul R Insider	273.4K	1.46%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.460% Rodriguez Raul R's insider activity →
SD Schorno Dean L Insider	83.0K	0.44%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.440% Schorno Dean L's insider activity →

Rodriguez Raul R

Insider

273.4K

% of company

1.46%

Change vs last qtr

—

Held since

—

Schorno Dean L

Insider

83.0K

% of company

0.44%

Change vs last qtr

—

Held since

—

10 more holders behind a free account

See every insider and 5%+ holder of Rigel Pharmaceuticals, Inc..

Comments